Advanced search
Publication Cover
Journal of Medical Economics Volume 16, 2013 - Issue 3
Submit an article Journal homepage
848
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Adapting a global cost-effectiveness model to local country requirements: posaconazole case study

George Papadopoulos Formerly with Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA; Current affiliation: Emerald Corporate Group Pty Ltd McMahons Point, NSWAustraliaCorrespondence[email protected]
,
Sheena HuntApotheCom Yardley, PAUSA
&
Manishi PrasadMerck Sharp & Dohme Corp. Whitehouse Station, NJUSA
Pages 374-380 | Accepted 18 Dec 2012, Published online: 08 Jan 2013

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

C. Beauchemin, N. Letarte, K. Mathurin, L. Yelle & J. Lachaine. (2016) A global economic model to assess the cost-effectiveness of new treatments for advanced breast cancer in Canada. Journal of Medical Economics 19:6, pages 619-629.
Read now
Anita H. Sung, Stephen W. Marcella & Yang Xie. (2015) An update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United States. Journal of Medical Economics 18:5, pages 341-348.
Read now
Isabel Sánchez-Ortega, Beatriz Patiño, Carmen Muñoz, Montserrat Arnan, Teresa Peralta, Ana Clopés, Alberto Fernández de Sevilla & Rafael F. Duarte. (2013) Cost-effectiveness of primary antifungal prophylaxis with posaconazole versus itraconazole in allogeneic hematopoietic stem cell transplantation. Journal of Medical Economics 16:6, pages 736-743.
Read now

Articles from other publishers (2)

Santiago Grau, Rafael Cámara, Manuel Jurado, Jaime Sanz, Belén Aragón & Irmina Gozalbo. (2017) Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. The European Journal of Health Economics 19:4, pages 627-636.
Crossref
Rafael Cámara, Irmina Gozalbo, Manuel Jurado, Jaime Sanz, Belén Aragón & Santiago Grau. (2017) Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain. Advances in Therapy 34:9, pages 2104-2119.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.